https://www.businesswire.com/news/home/20241107444629/en/Cofactor-Genomics-Publishes-Clinical-Validation-of-OncoPrism-HNSCC-a-Test-Leveraging-Novel-RNA-Modeling-Technology-to-Predict-Response-to-Immunotherapy
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA...
Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT clinical tr...